OSU‐T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells-Reference-Cited by-同舟云学术

OSU‐T315 and doxorubicin synergistically induce apoptosis via mitochondrial pathway in bladder cancer cells

Published:2022-07-13 Issue:10 Volume:46 Page:1672-1681
ISSN:1065-6995
Container-title:Cell Biology International
language:en
Short-container-title:Cell Biology International

Author:

Li Zhihui¹,Ren Danhong¹,Chen Chen²,Sun Leiming¹,Fang Kun¹^ORCID

Affiliation:

1. Department of Intensive Care Unit Hangzhou Red Cross Hospital/Hospital of Integrated Traditional Chinese and Western Medicine in Zhejiang Province Hangzhou Zhejiang China

2. Department of Urology The Affiliated Hospital of Ningbo University Ningbo Zhejiang China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbin.11855

Reference29 articles.

1. GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and Nutraceuticals

2. Atypical APC/C‐dependent degradation of Mcl‐1 provides an apoptotic timer during mitotic arrest

3. Integrin signaling and lung cancer

4. Autophagy and doxorubicin resistance in cancer

5. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized LC-MS/MS method for Doxorubicin quantification: validating drug uptake and tumor reduction in zebrafish xenograft model of breast cancer;2024-08-09

2. Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia;Cancer and Metastasis Reviews;2024-08-05

3. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents?;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy;Frontiers in Immunology;2023-05-05

5. EIF5A2 Promotes Doxorubicin Resistance in Bladder Cancer Cells through the TGF-β Signaling Pathway;Discovery Medicine;2023